Percutaneous transluminal angioplasty (PTA) is a procedure that opens up blocked peripheral arteries due to plaque build-up (atherosclerosis). Cerebral arteries in the brain, carotid arteries in the neck, renal arteries leading to the kidneys, abdominal arteries, iliac arteries in the groin, infrapopliteal arteries in the knee, and femoropopliteal arteries in the thighs are the peripheral arteries most commonly affected by atherosclerosis. A catheter is inserted into an artery, commonly in the groin, in the arm or wrist. A series of x-ray images are taken to clearly view the narrowed artery after the catheter is advanced into the narrowed artery. Then, a catheter with a balloon tip is advanced into the narrowed artery. The balloon is inflated and deflated numerous times inside the artery, compressing the plaque against the arterial wall and widening the artery to enhance blood flow.
Market Dynamics
Increasing launches of angioplasty balloons catheter products in the market by key players are expected to drive the global percutaneous transluminal angioplasty balloons catheter market growth during the forecast period. For instance, in March 2021, Medtronic Plc., a company engaged in the development, manufacturing, distribution, and sales of medical devices worldwide, announced the launch of Chameleon percutaneous transluminal angioplasty (PTA) balloon catheter in Italy, Germany, South Africa, Italy, Portugal, Spain, and Turkey. This device is intended for use in native or synthetic arteriovenous dialysis fistulae, as well as iliac, femoral, and renal arteries.
Key features of the study:
- This report provides an in-depth analysis of the global percutaneous transluminal angioplasty balloons catheter market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global percutaneous transluminal angioplasty balloons catheter market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Cook Group, Medtronic Plc., Becton, Dickinson and Company, Abbott Laboratories, Koninklijke Philips N.V., ENDOCOR GmbH, Cardinal Health, NIPRO, Terumo Corporation, Boston Scientific Corporation, Surmodics, Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Biomerics, Shockwave Medical Inc., Microport Scientific Corporation, Nordson Corporation, and S3V Vascular Technologies Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global percutaneous transluminal angioplasty balloons catheter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global percutaneous transluminal angioplasty balloons catheter market
Detailed Segmentation:
- Global Percutaneous Transluminal Angioplasty Balloons Catheter Market, By Type:
- Standard PTA Balloons
- High Pressure PTA Balloons
- Scoring PTA Balloons
- Cutting Balloons
- Drug Coated Balloon
- Lithotripsy Balloons
- Others (Stent graft balloon catheter)
- Global Percutaneous Transluminal Angioplasty Balloons Catheter Market, By Material:
- Polyurethane
- Nylon
- Others
- Global Percutaneous Transluminal Angioplasty Balloons Catheter Market, By Application:
- Peripheral Artery Disease
- Coronary Artery Disease
- Global Percutaneous Transluminal Angioplasty Balloons Catheter Market, By Diameter Size:
- 1 to 4 mm
- 4 to 8 mm
- > 8 mm
- Global Percutaneous Transluminal Angioplasty Balloons Catheter Market, By End User:
- Hospitals
- Cardiology Clinics
- Others
- Global Percutaneous Transluminal Angioplasty Balloons Catheter Market, By Region
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Cook Group*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Medtronic Plc.
- Becton, Dickinson and Company
- Abbott Laboratories
- Koninklijke Philips N.V.
- ENDOCOR GmbH
- Cardinal Health
- NIPRO
- Terumo Corporation
- Boston Scientific Corporation
- Surmodics, Inc.
- Teleflex Incorporated
- BIOTRONIK SE & Co. KG
- Biomerics
- Shockwave Medical Inc.
- Microport Scientific Corporation
- Nordson Corporation
- S3V Vascular Technologies Pvt. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
